CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Short-Term Progression of Multiterritorial Subclinical Atherosclerosis Negative Risk Markers for Cardiovascular Events in the Elderly Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Review Article2020 Dec;142(22):2172-2188.

JOURNAL:Circulation. Article Link

Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus

D Capodanno, DJ Angiolillo et al. Keywords: antithrombotic strategies; prevention; ASCVD; DM

Full Text PDF